Insights into London's Life Science Ecosystem, LSX World Congress & Bavarian Support in the UK
This web-seminar is part of our international "Biotech Goes Global" series, designed to open doors to key global markets. This session’s spotlight: United Kingdom. It will highlight London’s role as a leading life science hub with top-tier academic institutions, a thriving startup ecosystem, and major pharmaceutical companies. Let’s dive into the opportunities UK offers for Bavarian biotech companies.
This session will address essential aspects for companies in the health sector (including biotechnology, pharmaceuticals, medical technology, and digital health) interested in learning more about the sector in the UK, which has one of the most advanced and diversified life sciences and healthcare ecosystems in the world.
This session focuses on:
- The UK - a gateway between the US and the EU
- Key players within London’s life science ecosystem
- Strategic advice for participating in the LSX Conference
- Bavarian Representative Office in the UK
Speakers
- Greg Hands, UK Government Minister 2011-2024 in Finance, Trade, Energy and Climate
- Omer Safdar, Investment Manager, MedCity / London & Partners
- Anna Schennach, Director, Office of the Free State of Bavaria in United Kingdom
Agenda: Further details and the full agenda here.
This webinar is organized in cooperation with the Office of the Free State of Bavaria in United Kingdom and is embedded within the context of the Bavarian Booth at the LSX Conference. The session offers valuable guidance and tips to help participants make the most of their presence in the UK.
Registration: Participation is free of charge, but registration is required. Register electronically using the registration form below.